Evaluation of the Effect of Palm Olein Free Formula on Intestinal Flora and Gastrointestinal Tolerance

Sponsor
Kanuni Sultan Suleyman Training and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03770143
Collaborator
(none)
90
1
5
17.9

Study Details

Study Description

Brief Summary

Depending on recent studies in literature the investigators aimed to compare whether gastrointestinal tolerance differs between infants fed with palm olein containing or palm olein free formulas. Besides it is showed that palm olein containing formulas decreases the absorption of fat and calcium by forming insoluble calcium soaps. So it is suggested that intestinal flora might be affected as a reason of these specialties. This study also aimed to investigate with culture-independent methods whether feeding infants with palm olein free formula results in the modification of their intestinal microbiota in such a way that is similar to breastfed ones.

Condition or Disease Intervention/Treatment Phase
  • Other: Feeding with palm olein formula

Detailed Description

Recent studies in literature the investigators aimed to compare whether gastrointestinal tolerance differs between infants fed with palm olein containing or palm olein free formulas. Besides it is showed that palm olein containing formulas decreases the absorption of fat and calcium by forming insoluble calcium soaps. So it is suggested that intestinal flora might be affected as a reason of these specialties. This study also aimed to investigate with culture-independent methods whether feeding infants with palm olein free formula results in the modification of their intestinal microbiota in such a way that is similar to breastfed ones.

Study Design

Study Type:
Observational
Actual Enrollment :
90 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Evaluation of the Effect of Palm Olein Free Formula on Intestinal Flora and Gastrointestinal Tolerance
Study Start Date :
May 1, 2016
Actual Primary Completion Date :
Aug 1, 2016
Actual Study Completion Date :
Oct 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Group 1

Infants feeding predominantly with palm olein free formula if presence in addition to breast milk for 8 weeks of life

Other: Feeding with palm olein formula

Group 2

Infants feeding with other formulas including palm olein if presence in addition to breast milk for 8 weeks of life

Group 3

Having similar demographical properties with infants feeding with breast milk (gender, age, weight, height)

Outcome Measures

Primary Outcome Measures

  1. Stool consistency [10 weeks]

    Amsterdam Infant Stool Scale

Secondary Outcome Measures

  1. Bacteria Count [10 weeks]

    number of the copy of DNA of Intestinal Flora Content

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 3 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

The data of the patients who fulfilled the following criteria are evaluated.

  1. Term infants between 38 and 40 weeks of gestational age and/or with a birth weight of

2500grams who are either breastfed or formula fed.

Selection of the subgroup using oral nutrition

  1. Feeding predominantly with palm olein free formula if presence in addition to breast milk for 8 weeks of life

  2. Feeding with other formulas including palm olein if presence in addition to breast milk for 8 weeks of life Selection of the subgroup not using oral nutritional supplement (control group)

  3. Having similar demographical properties with infants feeding with breast milk (gender, age, weight, height)

Exclusion Criteria:
  • Infants with major congenital abnormalities will be excluded.

  • Infants with lack of data will also be excluded.

  • Infants, whose parents don't agree with informed consent, will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kanuni Sultan Suleyman Training and Research Hospital Istanbul Kucukcekmece Turkey 34303

Sponsors and Collaborators

  • Kanuni Sultan Suleyman Training and Research Hospital

Investigators

  • Study Director: Seda Yilmaz Semerci, Kanuni SSTRH

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Merih Cetinkaya, Associate Professor, MD,PhD, Kanuni Sultan Suleyman Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT03770143
Other Study ID Numbers:
  • ANCL034
First Posted:
Dec 10, 2018
Last Update Posted:
Apr 23, 2019
Last Verified:
Dec 1, 2018
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 23, 2019